The Onco Life Podcast
Welcome to The Onco Life Podcast, your trusted source for cancer care insights, treatment updates, and patient-centered education. Hosted by the team at Onco Life Centre in Kuala Lumpur, Malaysia, this podcast is designed to guide patients, caregivers, and listeners through every stage of the cancer journey.
Each episode features expert advice from our oncologists, wellness tips, treatment innovations, and answers to the most common questions about cancer types, therapies, and recovery.
🎧 Empowering you with knowledge, support, and compassionate care—every step of the way.
📍 Kuala Lumpur, Malaysia
🌐 Learn more at oncolifecentre.com
The Onco Life Podcast
New Lung Cancer Treatment: IDEAYA Seeks FDA Approval for Targeted Therapy IDE892
In this episode, we explore IDEAYA Biosciences’ request for FDA approval to begin clinical testing of IDE892, a new targeted therapy designed for patients with MTAP-deleted non-small cell lung cancer (NSCLC). This potential breakthrough drug represents a step forward in precision cancer treatment.
You’ll learn:
- What IDE892 is and how it works as a PRMT5 inhibitor
- Why MTAP-deleted NSCLC patients could benefit most from this treatment
- How Phase 1 clinical trials will test safety, dosing, and early effectiveness
- The unique MTA-cooperative mechanism that makes IDE892 more selective
- Potential combination strategies with other drugs like IDE397
- Why genetic testing plays a critical role in identifying treatment options
While IDE892 is still in early development, it highlights the growing promise of personalized therapies designed to target cancer’s genetic weaknesses.
Blog Link: New Lung Cancer Treatment May Soon Begin Clinical Trial: IDEAYA Seeks FDA Approval
Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.
Author: Dr. CHRISTINA NG VAN TZE
📍 Visit us at oncolifecentre.com
📞 Call: +603-2242-2620
📧 Book a consultation or ask a question — we're here to support your journey.